132 related articles for article (PubMed ID: 32569402)
1. Faster waning of the rubella-specific immune response in young pregnant women immunized with MMR at 15 months.
Kung WJ; Shih CT; Shih YL; Liu LY; Wang CH; Cheng YW; Liu HC; Lin CC
Am J Reprod Immunol; 2020 Oct; 84(4):e13294. PubMed ID: 32569402
[TBL] [Abstract][Full Text] [Related]
2. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
[TBL] [Abstract][Full Text] [Related]
3. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.
Plans P; de Ory F; Campins M; Álvarez E; Payà T; Guisasola E; Compte C; Vellbé K; Sánchez C; Lozano MJ; Aran I; Bonmatí A; Carreras R; Jané M; Cabero L
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1161-71. PubMed ID: 25666082
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF
Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
Crooke SN; Haralambieva IH; Grill DE; Ovsyannikova IG; Kennedy RB; Poland GA
Vaccine; 2019 Jun; 37(29):3876-3882. PubMed ID: 31126859
[TBL] [Abstract][Full Text] [Related]
8. Response to third rubella vaccine dose.
Siira L; Nøkleby H; Barlinn R; Riise ØR; Aaberge IS; Dudman SG
Hum Vaccin Immunother; 2018; 14(10):2472-2477. PubMed ID: 29771601
[TBL] [Abstract][Full Text] [Related]
9. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
[No Abstract] [Full Text] [Related]
10. Immunity to rubella: an Italian retrospective cohort study.
Bianchi FP; De Nitto S; Stefanizzi P; Larocca AMV; Germinario CA; Tafuri S
BMC Public Health; 2019 Nov; 19(1):1490. PubMed ID: 31703651
[TBL] [Abstract][Full Text] [Related]
11. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
[TBL] [Abstract][Full Text] [Related]
12. Comparing the rubella seronegativity in pregnant women who received one dose of rubella vaccine at different ages in Taiwan.
Shih CT; Chang YC; Wang HL; Lin CC
Vaccine; 2016 Sep; 34(40):4787-91. PubMed ID: 27544587
[TBL] [Abstract][Full Text] [Related]
13. Durability of humoral immune responses to rubella following MMR vaccination.
Crooke SN; Riggenbach MM; Ovsyannikova IG; Warner ND; Chen MH; Hao L; Icenogle JP; Poland GA; Kennedy RB
Vaccine; 2020 Dec; 38(51):8185-8193. PubMed ID: 33190948
[TBL] [Abstract][Full Text] [Related]
14. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
McLean HQ; Fiebelkorn AP; Ogee-Nwankwo A; Hao L; Coleman LA; Adebayo A; Icenogle JP
Vaccine; 2018 Sep; 36(38):5732-5737. PubMed ID: 30107992
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
16. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
18. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain.
Vilajeliu A; García-Basteiro AL; Valencia S; Barreales S; Oliveras L; Calvente V; Goncé A; Bayas JM
Vaccine; 2015 Apr; 33(15):1767-72. PubMed ID: 25731790
[TBL] [Abstract][Full Text] [Related]
19. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
Carryn S; Feyssaguet M; Povey M; Di Paolo E
Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
[TBL] [Abstract][Full Text] [Related]
20. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
